Acta Neuropathologica

, Volume 77, Issue 4, pp 337–342 | Cite as

Sulfated glycosaminoglycans in amyloid plaques of prion diseases

  • A. D. Snow
  • R. Kisilevsky
  • J. Willmer
  • S. B. Prusiner
  • S. J. DeArmond
Regular Papers

Summary

Brain sections from cases of human Creutzfeldt-Jakob disease, Gerstmann-Sträussler syndrome, kuru, and hamster scrapie containing amyloid were examined for the presence of sulfated glycosaminoglycans (GAGs), the anionic component of proteoglycans, using the sulfated Alcian blue method and Alcian blue technique with 0.3 M and 0.7 M magnesium chloride. These studies suggest that sulfated glycosaminoglycans are part of the CNS amyloid plaques in each of the above human prion disorders as well as in experimental scrapie. All the amyloid plaques stained positively with Alcian blue at 0.3 M, and less so at 0.7 M magnesium chloride indicating the presence of sulfated GAGs. Therefore, the amyloid plaques of prion diseases possess similar histochemical features to those found in Alzheimer's disease.

Key words

Amyloid Alzheimer's disease Glycosaminoglycans Proteoglycans Priom diseases 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beck E, Daniel PM, Parry HB (1964) Degeneration of the cerebellar and hypothalamo-neurohypophysial systems in sheep with scrapie, and its relationship to human system degenerations. Brain 87:153–176Google Scholar
  2. 2.
    Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB (1984) Antibodies to a scrapie prion protein. Nature 310:418–421Google Scholar
  3. 3.
    Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311Google Scholar
  4. 4.
    Bolton DC, Meyer RK, Prusiner SB (1985) Scrapie PrP 27-30 is a sialoglycoprotein. J Virol 53:596–606Google Scholar
  5. 5.
    Bruce M, Fraser M (1975) Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropathol Appl Neurobiol 1:189–202Google Scholar
  6. 6.
    DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41:221–235Google Scholar
  7. 7.
    DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37:1271–1280Google Scholar
  8. 8.
    Dorling J (1969) Critical electrolyte concentration method in histochemistry. J Med Lab Technol 26:124–130Google Scholar
  9. 9.
    Edwards RA, Woody RW (1979) Spectroscopic studies of Cibacron blue and Congo red bound to dehydrogenases and kinases. Evaluation of dyes as probes of the dinucleotide fold. Biochemistry 18:5197–5204Google Scholar
  10. 10.
    Gerstmann J, Sträussler E, Scheinker I (1936) Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol 154:736–762Google Scholar
  11. 11.
    Ihara Y, Abraham C, Selkoe DJ (1983) Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature 304:727–730Google Scholar
  12. 12.
    Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530–532Google Scholar
  13. 13.
    Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Methods in laboratory investigation; formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230–236Google Scholar
  14. 14.
    Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of kuru. Lab Invest 9:799–847Google Scholar
  15. 15.
    Lendrum AC, Sidders W, Fraser S (1972) Renal hyalin: a study of amyloidosis and diabetic fibrinous vasculosis with new staining methods. J Clin Pathol 25:373–396Google Scholar
  16. 16.
    Marsh RF, Kimberlin RH (1975) Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogenesis. J Infect Dis 131:104–110Google Scholar
  17. 17.
    Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain 104:535–558Google Scholar
  18. 18.
    Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) Creutzfeldt-Jakob disease virus isolations from the Gertmann-Sträussler syndrome: with analysis of various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104:559–588Google Scholar
  19. 19.
    Masters CL, Multhaup C, Simms C, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757–2763Google Scholar
  20. 20.
    McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57–62Google Scholar
  21. 21.
    McLean IW, Nakane PK (1974) Periodate-lysine-paraformaldehyde fixative. A new fixative for immuno-electron microscopy. J Histochem Cytochem 22:1077–1083Google Scholar
  22. 22.
    Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525–527Google Scholar
  23. 23.
    Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144Google Scholar
  24. 24.
    Prusiner SB (1987) Prions and neurodegenerative diseases. N Engl J Med 317:1571–1581Google Scholar
  25. 25.
    Prusiner SB, DeArmond SJ (1987) Biology of disease; prions causing nervous system denegeration. Lab Invest 56:349–363Google Scholar
  26. 26.
    Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM (1980) Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19:4883–4891Google Scholar
  27. 27.
    Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353–358Google Scholar
  28. 28.
    Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10:355–364Google Scholar
  29. 29.
    Scott JE, Dorling J (1965) Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 5:221–233Google Scholar
  30. 30.
    Snow AD, Kisilevsky R (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: a histochemical study. Lab Invest 53:37–44Google Scholar
  31. 31.
    Snow AD, Kisilevsky R, Stephens C, Anastassiades T (1987) Characterization of tissue and plasma glyosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest 56:665–675Google Scholar
  32. 32.
    Snow AD, Willmer J, Kisilevsky R (1987) Sulphated glycosaminoglycans: a common constituent of all amyloids? Lab Invest 56:120–123Google Scholar
  33. 33.
    Snow AD, Willmer JP, Kisilevsky R (1987) Sulphated glycosaminoglycans in Alzheimer's disease. Hum Pathol 18:506–510Google Scholar
  34. 34.
    Snow AD, Mar H, Nochlin D, Wight TN (1988) Ultrastructural immunolocalization of heparan sulfate proteoglycans to amyloid fibrils in the neuritic plaques of Alzheimer's disease. J Neuropathol Exp Neurol 47:355 [abstr]Google Scholar
  35. 35.
    Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229–240Google Scholar
  36. 36.
    Szumanska G, Vorbrodt AW, Wisniewski HM (1986) Lectin histochemistry of scrapie amyloid plaques. Acta Neuropathol (Berl) 69:205–212Google Scholar
  37. 37.
    Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve R (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528–530Google Scholar
  38. 38.
    Vorbrodt AW, Dobrogowska DH, Kim YS, Lossinsky AS, Wisniewski HM (1988) Ultrastructural studies of glycoconjugates in brain micro-blood vessels and amyloid plaques of scrapie-infected mice. Acta Neuropathol (Berl) 75:277–287Google Scholar
  39. 39.
    Willmer JP, Snow AD, Kisilevsky R (1986) The demonstration of sulfated glycosaminoglycans (GAGs) in association with the amyloidotic lesions of Alzheimer's disease. J Neuropathol Exp Neurol 45:340 [abstr]Google Scholar
  40. 40.
    Wisniewski HM, Bruce ME, Fraser H (1975) Infectious etiology of neuritic (senile) plaques in mice. Science 190:1108–1110Google Scholar
  41. 41.
    Wong CW, Quaranta V, Glenner GG (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 82: 8729–8732Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • A. D. Snow
    • 1
  • R. Kisilevsky
    • 1
  • J. Willmer
    • 1
  • S. B. Prusiner
    • 3
    • 4
  • S. J. DeArmond
    • 2
    • 3
  1. 1.Departments of Pathology and BiochemistryQueen's University and Kingston General HospitalKingstonCanada
  2. 2.Department of PathologyUniversity of CaliforniaSan Francisco
  3. 3.Department of NeurologyUniversity of CaliforniaSan Francisco
  4. 4.Department of Biochemistry and BiophysicsUniversity of CaliforniaSan Francisco

Personalised recommendations